Kevin Clark

Senior Vice President, Global Ophthalmology Commercial Business Unit · Regeneron Pharmaceuticals

Biopharmaceuticals

Kevin Clark is senior vice president of the global ophthalmology commercial business unit at Regeneron Pharmaceuticals. He joined in 2019 after sixteen years at Novartis Pharmaceuticals. His responsibilities include commercial strategy, execution and development of the ophthalmology business team.

Last reviewed: Oct 21, 2026

Kevin Clark

Senior Vice President, Global Ophthalmology Commercial Business Unit Regeneron Pharmaceuticals

Last Reviewed: October 21, 2026

Executive Summary

Kevin Clark is senior vice president of the global ophthalmology commercial business unit at Regeneron Pharmaceuticals. He joined in 2019 after sixteen years at Novartis Pharmaceuticals. His responsibilities include commercial strategy, execution and development of the ophthalmology business team.

Career Highlights

  • Joined Regeneron in 2019.
  • Leads the global ophthalmology commercial business unit.
  • Previously held increasingly responsible roles during sixteen years at Novartis Pharmaceuticals.

Professional Journey

Clark developed his pharmaceutical career at Novartis Pharmaceuticals, where he spent sixteen years in roles of increasing responsibility. Regeneron’s current biography does not specify the titles or dates of those individual assignments.

He joined Regeneron in 2019 and now serves as senior vice president of the Global Ophthalmology Commercial Business Unit. His team is responsible for the commercial strategy and execution supporting the company’s ophthalmology business, including recruiting and developing employees.

The position connects business planning with the organization delivering ophthalmology medicines to the market. It is a commercial leadership role rather than a clinical research or physician appointment. The reviewed primary biography does not date his promotion to senior vice president or identify individual launch outcomes attributable to him; neither is inferred. His documented career chain is Novartis followed by Regeneron.

Education

Clark earned a BA from the University of Maryland. His field of study is not specified in the reviewed corporate biography.